These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8328384)
1. Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy. Perrone-Filardi P; Bacharach SL; Dilsizian V; Panza JA; Maurea S; Bonow RO Am J Cardiol; 1993 Jul; 72(2):199-204. PubMed ID: 8328384 [TBL] [Abstract][Full Text] [Related]
2. Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. Grover-McKay M; Schwaiger M; Krivokapich J; Perloff JK; Phelps ME; Schelbert HR J Am Coll Cardiol; 1989 Feb; 13(2):317-24. PubMed ID: 2783595 [TBL] [Abstract][Full Text] [Related]
3. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction. Perrone-Filardi P; Bacharach SL; Dilsizian V; Maurea S; Marin-Neto JA; Arrighi JA; Frank JA; Bonow RO J Am Coll Cardiol; 1992 Jul; 20(1):161-8. PubMed ID: 1607518 [TBL] [Abstract][Full Text] [Related]
4. Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study. Knaapen P; van Dockum WG; Götte MJ; Broeze KA; Kuijer JP; Zwanenburg JJ; Marcus JT; Kok WE; van Rossum AC; Lammertsma AA; Visser FC J Nucl Cardiol; 2006 Sep; 13(5):660-7. PubMed ID: 16945746 [TBL] [Abstract][Full Text] [Related]
10. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. Camici P; Chiriatti G; Lorenzoni R; Bellina RC; Gistri R; Italiani G; Parodi O; Salvadori PA; Nista N; Papi L J Am Coll Cardiol; 1991 Mar; 17(4):879-86. PubMed ID: 1999624 [TBL] [Abstract][Full Text] [Related]
11. Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or nonobstructive hypertrophic cardiomyopathy. Maron BJ Eur Heart J; 1983 Nov; 4 Suppl F():73-91. PubMed ID: 6686547 [TBL] [Abstract][Full Text] [Related]
12. Differences in myocardial fluoro-18 2-deoxyglucose uptake in young versus older patients with hypertrophic cardiomyopathy. Kagaya Y; Ishide N; Takeyama D; Kanno Y; Yamane Y; Shirato K; Maruyama Y; Itoh M; Ido T; Matsuzawa T Am J Cardiol; 1992 Jan; 69(3):242-6. PubMed ID: 1731466 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of regional contractile dynamics and pathological findings of the left ventricular wall in patients with hypertrophic cardiomyopathy]. Usuki S; Yokota Y; Maehashi N; Nakanishi M; Nakanishi O; Emoto R; Kurozumi H; Miki T; Fukuzaki H; Ito H J Cardiol; 1988 Sep; 18(3):665-72. PubMed ID: 3249283 [TBL] [Abstract][Full Text] [Related]
14. Regional heterogeneity of function in hypertrophic cardiomyopathy. Kramer CM; Reichek N; Ferrari VA; Theobald T; Dawson J; Axel L Circulation; 1994 Jul; 90(1):186-94. PubMed ID: 8025995 [TBL] [Abstract][Full Text] [Related]